title: Incidence of milk alkali syndrome in the Women's Health Initiative clinical trial and cohort study: response to Neupane.
authors.affiliation: , 1100 Fairview Ave N, M3-A410, POB 19024, Seattle, WA, USA, rprentic@whi.org.
authors.forename: R L
authors.initials: RL
authors.lastname: Prentice
authors.forename: R D
authors.initials: RD
authors.lastname: Jackson
authors.forename: M
authors.initials: M
authors.lastname: Pettinger
authors.forename: J E
authors.initials: JE
authors.lastname: Rossouw
mesh_terms: D050071:Bone Density Conservation Agents / Q000627:therapeutic use*; D002119:Calcium Carbonate / Q000627:therapeutic use*; D002762:Cholecalciferol / Q000627:therapeutic use*; D019587:Dietary Supplements / Q000009:adverse effects*; D005260:Female; D006801:Humans; D058866:Osteoporotic Fractures / Q000517:prevention & control*
chemical_list: D050071:Bone Density Conservation Agents; D002762:Cholecalciferol; D002119:Calcium Carbonate
references.citation: Osteoporos Int. 2013 Feb;24(2):567-80
references.pmid: 23208074
references.citation: Osteoporos Int. 2014 Mar;25(3):1193
references.pmid: 23912557